Implementation considerations for multisite clinical trials with cognitive neuroscience tasks.
暂无分享,去创建一个
[1] M. Davidson,et al. Cognitive impairment as a target for pharmacological treatment in schizophrenia , 1995, Schizophrenia Research.
[2] Philip D. Harvey,et al. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery , 2004, Schizophrenia Research.
[3] Barbara A. Cornblatt,et al. The continuous performance test, identical pairs version: II. Contrasting attentional profiles in schizophrenic and depressed patients , 1989, Psychiatry Research.
[4] J. Gold,et al. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. , 2007, Archives of general psychiatry.
[5] Philip D. Harvey,et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury , 2006, Neurology.
[6] J. Lieberman,et al. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. , 1999, Schizophrenia bulletin.
[7] Philip D. Harvey,et al. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial. , 2005, The American journal of psychiatry.
[8] K. Davis,et al. Assessing changes in Alzheimer's disease: Memory and language. , 1986 .
[9] J. Lieberman,et al. Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia , 2008, Journal of the International Neuropsychological Society.
[10] J. Lieberman,et al. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. , 2004, The American journal of psychiatry.
[11] Michael F. Green,et al. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia , 2004, Schizophrenia Research.
[12] Philip D. Harvey,et al. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. , 2001, The American journal of psychiatry.
[13] R. Gur,et al. A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis , 2006, Schizophrenia Research.
[14] Michael F. Green,et al. Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial , 2006, Neuropsychopharmacology.
[15] K. Davis,et al. Handbook for clinical memory assessment of older adults , 1986 .
[16] References , 1971 .